French Glendon E. III

Director · Officer · LUNG

As of 2026-09-16, French Glendon E. III has 18 Form 4 transactions on record across 1 company — 12 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Pattern in the record: open-market sales filed in March in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.

Reconstructed holdings

Direct: $2.2MIndirect: $0$2.2Mas of 2026-09-16
  • Direct $2.2M
  • Indirect $0
LUNGdirect1,137,936 sh$2.2M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

LUNG · 18 trades
2026-09-01: Sale, 37,784 sh ($85K)2026-09-01: Sale, 4,098 sh ($9K)2026-06-02: Sale, 13,511 sh ($21K)2026-06-01: Sale, 38,467 sh ($59K)2026-06-01: Sale, 4,171 sh ($6K)2026-03-02: Sale, 58,368 sh ($83K)2026-03-02: Sale, 6,737 sh ($10K)2026-03-02: Sale, 2,708 sh ($4K)2025-12-01: Sale, 6,281 sh ($10K)2025-12-01: Sale, 2,524 sh ($4K)2025-12-01: Award / grant, 800,000 sh ($0)2025-12-01: Award / grant, 1,200,000 sh ($0)2025-06-02: Award / grant, 37,153 sh ($0)2025-03-20: Sale, 20,000 sh ($157K)2025-02-20: Sale, 43,036 sh ($350K)2025-02-20: Sale, 12,417 sh ($109K)2025-01-17: Sale, 2,221 sh ($14K)2025-01-16: Sale, 2,326 sh ($15K)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-09-01LUNGSale37,784 @ $2.26$85K−3.2% of holding1,137,936Form 4
2026-09-01LUNGSale4,098 @ $2.26$9K−0.3% of holding1,175,720Form 4
2026-06-02LUNGSale13,511 @ $1.57$21K−1.1% of holding1,178,162Form 4
2026-06-01LUNGSale38,467 @ $1.54$59K−3.1% of holding1,191,673Form 4
2026-06-01LUNGSale4,171 @ $1.54$6K−0.3% of holding1,230,140Form 4
2026-03-02LUNGSale58,368 @ $1.43$83K−4.0% of holding1,409,511Form 4
2026-03-02LUNGSale6,737 @ $1.43$10K−0.5% of holding1,467,879Form 4
2026-03-02LUNGSale2,708 @ $1.43$4K−0.2% of holding1,474,616Form 4
2025-12-01LUNGSale6,281 @ $1.57$10K−2.2% of holding277,324Form 4
2025-12-01LUNGSale2,524 @ $1.57$4K−0.9% of holding283,605Form 4
2025-03-20LUNGSale20,000 @ $7.85$157K−2.0% of holding991,974Form 4
2025-02-20LUNGSale43,036 @ $8.14$350K−4.0% of holding1,024,391Form 4
2025-02-20LUNGSale12,417 @ $8.76$109K−1.2% of holding1,011,974Form 4
2025-01-17LUNGSale2,221 @ $6.50$14K−0.2% of holding1,067,427Form 4
2025-01-16LUNGSale2,326 @ $6.53$15K−0.2% of holding1,069,648Form 4
3 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2025-12-01LUNGAward / grant800,000800,000Form 4
2025-12-01LUNGAward / grant1,200,0001,477,324Form 4
2025-06-02LUNGAward / grant37,1531,029,127Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.